February 3, 2025  -  InvestmentInvestment Round-upsNews

Women’s Health Investment Round-up (January 2025)

Investments

Delfina secures $17M Series A to Scale AI-Powered Maternal Health Platform. Link

Allara raises $26M Series B to scale virtual hormonal healthcare platform. Link

Sunfish raises $10M Series A to make IVF more accessible and predictable.

Women’s health diagnostics company PinkDx raises $5M in Series A extension; bringing total to $45M.

Gaia secures $14M to scale fertility insurance platform in the US.

Women’s heart health platform Systole Health launches with $2M pre-seed round.

Teal Health raises $10M to launch at-home cervical cancer screening device.

Egal raises $4M Series A to make period products as accessible as toilet paper.

Gesynta Pharma raises $29M to advance non-hormonal endometriosis treatment.

Lilly acquires breast cancer treatment program from Scorpion Therapeutics in $2.5B deal.

Indian digital health platform Raaz raises $1M to address male reproductive health.

Kegg creator Lady Technologies raises $6.5M Series A to expand vaginal health platform.

Conceivable Life Sciences raises $18M to automate IVF labs.

Femble raises €350K; pivots from cycle app to healthcare content platform.

Singapore’s Aura Fem Health raises $200K for personalized women’s health platform.

French startup Mabel raises €600K to launch psychedlic-based women’s health platform.

Women’s Heatlh AI platform Ema secures additional funding bringing total to $3M.

Acquisitions

Progyny acquires parental leave navigation platform BenefitBump.

Metronomicacquires Iron Health to scale OB/GYN practice support platform.

ScreenPoint Medical acquires Biomediq to enhance breast cancer risk assessment.